Coagulation and inflammation in experimental endotoxemia in vitro and in vivo : monitoring method and effects of nicotinamide
Author: Ungerstedt, Johanna S
Date: 2003-03-28
Location: Medicinklinikens föreläsningssal, 4tr, Karolinska Sjukhuset
Time: 9.00
Department: Institutionen för kirurgisk vetenskap / Department of Surgical Science
View/ Open:
Thesis (763.1Kb)
Abstract
In gram negative sepsis, endotoxin from the bacterial membrane elicits proinflammatory and procoagulant host responses. Sepsis and its frequent complication disseminated intravascular coagulation (DIC) are leading causes of morbidity and mortality in the intensive care. A pivotal mechanism in the pathogenesis of DIC is the expression of tissue factor (TF) on circulating monocytes after endotoxin encounter. Activation of the cascade systems of coagulation and inflammation can lead to a rapid deterioration in e.g. sepsis with procoagulant changes and microthromboses, resulting in DIC and multi organ failure. Monitoring of the degree of coagulation activation, to discover changes before clinical exacerbation, is critical.
We have established a global monitoring method for coagulation activity, clotting onset time (COT), based on free oscillating rheometry. The assay design mimicks the natural blood milieu, as the method is based on CaC12 repletion of blood or plasma, adding no artificial activators or inhibitors. The COT method proved to be a quick and reliable test, able to detect hypoand hypercoagulation. It also showed promising results as a bedside monitoring method, able to detect the transient activation of coagulation caused by intravenous injection of endotoxin to healthy volunteers. We also demonstrate that the COT method is sensitive even to small changes in the amount of endotoxin induced monocyte surface TF. In neurotrauma patients, COT was a predictor of prognosis for the patients. This observation, however, is difficult to interpret and requires further investigation.
The vitamin B derivative nicotinamide was assessed for its potential modulating effects on endotoxin induced activation of coagulation and inflammation. Nicotinamide is a known PARP inhibitor. PARP is necessary for activation of the transcription factor NFkappabeta, responsible for transcription of many genes involved in the response to endotoxin, e.g. proinflammatory cytokines, giving a rationale for a potential beneficial effect of nicotinamide in endotoxemia. We demonstrate that nicotinamide is a potent inhibitor of three major endotoxin induced proinflammatory cytokines, Il-1 beta, IL-6 and IL-8, in addition to the previously known TNFalpha inhibiting effect. However, the dose dependent inhibition of endotoxin induced proinflammatory responses was shown unlikely to be due to PARP inhibition. In endotoxin stimulated leukocyte suspensions as well as in whole blood, nicotinamide caused a dose dependent decrease of monocyte TF expression, describing a previously unknown inhibitory effect of nicotinamide on the procoagulant changes associated with endotoxemia. We have also demonstrated that the decrease of monocyte TF expression is at least partly caused by shedding from the monocyte surface. Our conclusion is that nicotinamide may have a therapeutic potential in modulating conditions associated with activation of coagulation and inflammation, such as in sepsis and DIC.
We have established a global monitoring method for coagulation activity, clotting onset time (COT), based on free oscillating rheometry. The assay design mimicks the natural blood milieu, as the method is based on CaC12 repletion of blood or plasma, adding no artificial activators or inhibitors. The COT method proved to be a quick and reliable test, able to detect hypoand hypercoagulation. It also showed promising results as a bedside monitoring method, able to detect the transient activation of coagulation caused by intravenous injection of endotoxin to healthy volunteers. We also demonstrate that the COT method is sensitive even to small changes in the amount of endotoxin induced monocyte surface TF. In neurotrauma patients, COT was a predictor of prognosis for the patients. This observation, however, is difficult to interpret and requires further investigation.
The vitamin B derivative nicotinamide was assessed for its potential modulating effects on endotoxin induced activation of coagulation and inflammation. Nicotinamide is a known PARP inhibitor. PARP is necessary for activation of the transcription factor NFkappabeta, responsible for transcription of many genes involved in the response to endotoxin, e.g. proinflammatory cytokines, giving a rationale for a potential beneficial effect of nicotinamide in endotoxemia. We demonstrate that nicotinamide is a potent inhibitor of three major endotoxin induced proinflammatory cytokines, Il-1 beta, IL-6 and IL-8, in addition to the previously known TNFalpha inhibiting effect. However, the dose dependent inhibition of endotoxin induced proinflammatory responses was shown unlikely to be due to PARP inhibition. In endotoxin stimulated leukocyte suspensions as well as in whole blood, nicotinamide caused a dose dependent decrease of monocyte TF expression, describing a previously unknown inhibitory effect of nicotinamide on the procoagulant changes associated with endotoxemia. We have also demonstrated that the decrease of monocyte TF expression is at least partly caused by shedding from the monocyte surface. Our conclusion is that nicotinamide may have a therapeutic potential in modulating conditions associated with activation of coagulation and inflammation, such as in sepsis and DIC.
List of papers:
I. Ungerstedt JS, Kallner A, Blomback M (2002). Measurement of blood and plasma coagulation time using free oscillating rheometry. Scand J Clin Lab Invest. 62(2): 135-40.
Pubmed
II. Ungerstedt JS, Grenander A, Bredbacka S, Blomback M (2003). Clotting onset time may be a predictor of outcome in human brain injury: a pilot study. J Neurosurg Anesthesiol. 15(1): 13-8.
Pubmed
III. Ungerstedt JS, Blomback M, Soderstrom T (2003). Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol. 131(1): 48-52.
Pubmed
IV. Ungerstedt JS, Soop A, Sollevi A, Blomback M (2003). Whole blood coagulation activation after challenging healthy volunteers with intravenous endotoxin. [Submitted]
V. Ungerstedt JS, Heimersson K, Soderstrom T, Hansson M (2003). Nicotinamide inhibits endotoxin induced monocyte TF expression. [Submitted]
I. Ungerstedt JS, Kallner A, Blomback M (2002). Measurement of blood and plasma coagulation time using free oscillating rheometry. Scand J Clin Lab Invest. 62(2): 135-40.
Pubmed
II. Ungerstedt JS, Grenander A, Bredbacka S, Blomback M (2003). Clotting onset time may be a predictor of outcome in human brain injury: a pilot study. J Neurosurg Anesthesiol. 15(1): 13-8.
Pubmed
III. Ungerstedt JS, Blomback M, Soderstrom T (2003). Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol. 131(1): 48-52.
Pubmed
IV. Ungerstedt JS, Soop A, Sollevi A, Blomback M (2003). Whole blood coagulation activation after challenging healthy volunteers with intravenous endotoxin. [Submitted]
V. Ungerstedt JS, Heimersson K, Soderstrom T, Hansson M (2003). Nicotinamide inhibits endotoxin induced monocyte TF expression. [Submitted]
Issue date: 2003-03-07
Rights:
Publication year: 2003
ISBN: 91-7349-477-1
Statistics
Total Visits
Views | |
---|---|
Coagulation ...(legacy) | 805 |
Coagulation ... | 122 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Coagulation ... | 0 | 2 | 1 | 0 | 1 | 0 | 3 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 230 |
thesis.pdf | 40 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 405 |
Sweden | 81 |
China | 63 |
Germany | 53 |
South Korea | 16 |
United Kingdom | 15 |
Finland | 10 |
Ireland | 9 |
Denmark | 7 |
Russia | 7 |
Top cities views
Views | |
---|---|
Sunnyvale | 47 |
Romeo | 39 |
Beijing | 35 |
Kiez | 18 |
Seoul | 15 |
Stockholm | 10 |
Dublin | 9 |
London | 8 |
Ballerup | 6 |
University Park | 5 |